Acne Vulgaris - 475 Studies Found Completed : Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris : Acne Vulgaris : 2008-09-11 : Drug: Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiol Completed : A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris : Acne Vulgaris : 2009-11-19 : Drug: Tazarotene Topical Tazar Completed : CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris : Acne Vulgaris : 2015-03-05 : Drug: CTX-4430 Drug: Placebo Recruiting : Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris : Acne Vulgaris : 2016-09-30 : Device: Venus Versa Enrolling by invitation : An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris : Acne Vulgaris : 2016-02-10 : Drug: CB-03-01 cream, 1% CB-03-01 (cortexolone 17α-propionate) is a steroidal antiandrogen that is Completed : Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of P005672 in Treatment of Facial Acne Vulgaris : Acne Vulgaris : 2012-06-22 : Drug: 50 mg P005672 50 mg P000 Recruiting : A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) : Acne Vulgaris : 2015-11-17 : Drug: CB-03-01 cream, 1% CB-03 Recruiting : A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) : Acne Vulgaris : 2015-11-17 : Drug: CB-03-01 cream, 1% CB-03 Completed : Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris : Acne Vulgaris : 2011-03-21 : Drug: CD2475/101 40 mg Tablets Withdrawn : TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris : Acne Vulgaris : 2016-05-26 : Drug: Vehicle Applied once a d <<< Previous | Next >>>
